Zenotech Laboratories Ltd. is significantly underperforming its peers in terms of growth, profitability, and valuation metrics. While other companies in the sector show profitable operations and attractive growth rates, Zenotech struggles with negative growth and returns, making it a less favorable investment option.

• • Zenotech Laboratories has negative revenue growth and EPS, indicating underlying operational issues.
• • Cipla Ltd. and Dr. Reddy's Laboratories are standout performers with strong profitability and growth metrics.
• • Sun Pharmaceutical Industries appears overvalued despite its profitability due to a high PE ratio.
• • Zenotech is financially weak with a low ROE and negative profit margins.